How is GenCoE facilitating pharmaceutical collaboration?

GenCoE is working to ensure ethical pharmaceutical partnerships through PAGRA. This includes comprehensive contractual frameworks (pharma partners receive non-exclusive use rights for internal R&D efforts), prohibition on commercial redistribution, two-year publication embargo protecting African publication rights, annual progress reporting requirements, and adherence to strict ethical governance. Benefit sharing is incorporated through commitment to developing products addressing African healthcare needs and contributing to capacity development. Industry research may contribute to discovery of therapeutic targets and diagnostics, with pharma partners owning IP from their analyses while sample providers retain ownership of their data and IP from their own analyses. PAGRA are also providing legal guidance to ensure that the project complies with consents and data protection laws of the countries involved. The governance framework imposes strict restrictions on the movement and use of the data.